Post-synaptic dendritic spines are structurally composed of actin cytoskeleton, which undergoes dynamic morphological changes to accommodate incoming synaptic activity. Drebrin is an actin-binding protein highly expressed in dendritic spines that serves an important role in regulating spine morphology. Functionally, loss of drebrin directly correlates with deficits in learning and memory, as is the case observed in Alzheimer's disease. Despite these findings, the regulatory factor responsible for drebrin loss remains unclear. Here, we show that early growth response-1 (Egr-1), an inducible zinc finger transcription factor, down-regulates drebrin expression. Chromatin immunoprecipitation analyses identified Egr-1 binding sites upstream of the drebrin start site in neuronal cells. Overexpression of Egr-1 in vitro in primary hippocampal neurons or in vivo in homogenates prepared from the hippocampi of an inducible mouse model of Egr-1 show reduced drebrin mRNA and protein levels. Conversely, increased drebrin was detected in hippocampal samples isolated from Egr-1-deficient brain. These data demonstrate that Egr-1 interacts with the drebrin promoter and negatively regulates drebrin expression. Furthermore, immunocytochemical and Golgi staining analyses revealed reduced drebrin protein and dendritic spine density as well as reduced expression of synaptic markers in in vitro hippocampal neurons over-expressing Egr-1 and in vivo inducible mouse model of Egr-1. In contrast, increased drebrin expression correlated with increased dendritic spine density was detected in samples from Egr-1-deficient mice. These data provide evidence that Egr-1 is a novel regulator of drebrin expression, which is linked to changes in dendritic spine density.
In the mammalian forebrain, dendritic spines are small, protrusive boutons on dendrites that encapsulate the postsynaptic elements of synapses. Structurally, dendritic spines are mainly composed of the actin cytoskeleton. In response to synaptic activity, the actin cytoskeleton undergoes rapid rearrangement, changing the morphology of dendritic spines. This rearrangement of actin, in turn, forms the structural basis of synaptic plasticity (Fifkova and Delay 1982; Matus et al. 1982; Hayashi et al. 1996; Lang et al. 2004; Tsai et al. 2004) . The synaptic plasticity of dendritic spines is believed to be central to learning and memory formation (Xu et al. 2009; Roberts et al. 2010; Sala and Segal 2014) , and thus, highlights the importance of spine dynamics.
Drebrin is an actin-binding protein (ABP) that is expressed highly in neurons and localizes to dendritic spines to regulate their changes in morphology and density (Shirao 1995; Hayashi et al. 1996; Sekino et al. 2007) . Drebrin can stabilize actin filaments by binding to their sides (Mikati et al. 2013; Worth et al. 2013) . Drebrin is necessary for spine morphogenesis and maturation, as it recruits the postsynaptic scaffolding protein PSD-95 and the glutamate receptor N-methyl-D-aspartate receptors (NMDARs), which are crucial components of a functional dendritic spine (Mizui et al. 2005; Takahashi et al. 2006) . Deliberate downregulation of drebrin expression in vitro using either antisense nucleotides or shRNA has suppressed F-actin accumulation within dendritic spines, prevented formation of the spines, and reduced spine density (Takahashi et al. 2003 (Takahashi et al. , 2006 Yamazaki et al. 2014) . Furthermore, down-regulation of drebrin led to a decrease in both glutamatergic and GABAergic synaptic activities in hippocampal neurons in vitro (Ivanov et al. 2009 ).
Functionally, drebrin loss is linked with altered dendritic spine morphology and memory loss in humans and rodents. Antisense knockdown of drebrin in rat brain caused deficits in memory formation, sensorimotor gating, and cognitive function (Kobayashi et al. 2004) . Similarly, Drebrin-deficient mice showed deficits in memory function during contextual fear conditioning (Kojima et al. 2010) ; loss of dendritic spine number; loss of mushroom, thin and stubby spines; reduced levels of dopamine receptor D1 and D2; and inhibition of memory-related high-frequency induced synaptic strengthening (Jung et al. 2015) . Furthermore, drebrin loss is observed in postmortem brains of cognitive disorders such as Down's syndrome (Shim and Lubec 2002) , mild cognitive impairment (Harigaya et al. 1996; Hatanpaa et al. 1999; Counts et al. 2006) , and Alzheimer's disease (AD) (Shim and Lubec 2002; Counts et al. 2012) as well as in animal models of AD (Calon et al. 2004; Mahadomrongkul et al. 2005; Zhao et al. 2006; Lacor et al. 2007 ). However, despite its functional importance, the regulatory factor(s) of drebrin remain largely uncharacterized.
Early growth response gene-1 (Egr-1), also known as krox-24, TIS8, ngfi-a, zif-268 and ZENK (an acronym for the avian orthologue of the mammalian genes: zif-268, egr-1, ngfi-a and krox-24), is a zinc finger transcription factor that regulates diverse cellular processes including immune function, cell proliferation/growth, female reproduction, apoptosis, vascular function, learning, and memory (Lee et al. 1996; Knapska and Kaczmarek 2004) . Egr-1 regulates transcription via its Cys2His2 zinc finger motifs which recognize and bind GC-rich 9 base pair Egr-1 response elements (EREs) (GCG(G/T)GGGCG) on its target genes (Chavrier et al. 1988; Crosby et al. 1991) . A link between drebrin and Egr-1 was suggested using microarray analyses where Egr-1 over-expression in pheochromocytoma (PC12) cells led to reduced drebrin mRNA (James et al. 2005) . Interestingly, recent studies have found elevation of Egr-1 expression in AD and in a mouse model of AD (MacGibbon et al. 1997; Gomez Ravetti et al. 2010; Bakalash et al. 2011; Lu et al. 2011; Gatta et al. 2014; Killick et al. 2014) .
Taken together, these data led us to hypothesize that Egr-1-mediates regulation of drebrin levels in the brain. Therefore, in this study, we sought to test this possibility in Egr-1 overexpressing and Egr-1À/À mice as well as primary hippocampal neuronal culture. We demonstrate that Egr-1 negatively regulates drebrin expression by interacting with the drebrin promoter, and up-regulation of Egr-1 leads to loss of dendritic spines. Our data show a novel role of Egr-1 in regulation of drebrin and dendritic spines.
Materials and methods
Antibodies Antibodies were purchased. Mouse monoclonal anti-drebrin (ab12350, RRID: AB_299034), rabbit polyclonal anti-cofilin (ab42824, RRID: AB_879739), and rabbit polyclonal anti-profilin 1 (ab180830, RRID: AB_2636952) were from Abcam (Toronto, ON, USA); rabbit monoclonal anti-PSD-95 (#3450, RRID: AB_2292883) and mouse monoclonal anti-Myc tag (#2276, RRID: 331783) were from Cell Signaling Inc., (Danvers, MA, USA); mouse monoclonal anti-GAPDH (MAB374, RRID: 2107445) and rabbit polyclonal anti-GluA1 (AB1504, RRID: AB_2113602) were from Millipore, (Toronto, ON, USA); rabbit polyclonal anti-Egr-1 (sc-110x, RRID: AB_2097174) was from Santa Cruz Biotechnology, (Dallas, TX, USA); and mouse monoclonal anti-vGluT1 (clone N28/9, RRID: AB_10673111) was from NeuroMab, (Davis, CA, USA). For immunoblotting, horseradish peroxidase-conjugated goat anti-mouse IgG (RRID: AB_430834) and anti-rabbit IgG antibodies (RRID: AB_430833) were from Promega, (Madison, WI, USA). For immunocytochemistry, goat anti-mouse or antirabbit IgG (H+L) secondary antibodies complexed with Alexa Fluor â 555 (RRID: AB_10561552), 594 (RRID: AB_2556545), and 647 (RRID: AB_2535804) were from ThermoFisher Scientific, (Waltham, MA, USA). Acti-stain Alexa Fluor â 488 phalloidin (RRID: AB_2636954) was from Cytoskeleton, (Denver, CO, USA).
Animals
All procedures were approved by the Lady Davis Institute/Jewish General Hospital Animal Care Committee and were performed according to the guidelines of the Canadian Council on Animal Care. All mice were kept under a normal 12 h light/dark cycle, and had access to food and water ad libitum. All efforts were made to minimize animal suffering and the number of animals used.
A priori sample size calculations were made using the software G*Power (Faul et al. 2007 (Faul et al. , 2009 Charan and Biswas 2013 ) based on preliminary experiments. A two-tailed unpaired t-test with a type I error rate of a = 0.05 and power of 1-b > 0.8 was used. Consequently, for all of our immunoblotting and qRT-PCR a total sample size of n = 6 age-matched mice were used per group, while for Golgi staining a total sample size of n = 4 were used per group. Both male and female mice were used for our studies. Egr-1À/À mice (Lee et al. 1995) , a gift from Dr. Jeffrey Milbrandt (Washington University, St. Louis, MO, USA), were genotyped by PCR using gene-specific primers (Li et al. 2007) ; 12-mo Egr-1À/À, +/À and +/+ mice on a C57Bl/6j background were used (Lee et al. 1995) . Additionally, an inducible transgenic (Tg) mouse model of Egr-1 over-expression was generated to complement the Egr-1À/À mouse model. Egr-1 Tg mice were created using the tetracycline (tet)-off system to modulate the expression of Egr-1 spatiotemporally. Human Egr-1 cDNA was inserted into pBI (Clontech Laboratories, Mountain View, CA, USA), and gene modified mice created by the IRIC Transgenic Core Facility (University of Montreal, Montreal, QC, USA). Transgene-positive founder mice were crossbred with transgenic mice expressing the tetracyclinecontrolled transactivator protein under the control of the forebrainspecific calcium/calmodulin-dependent protein kinase IIa (CamKIIa) promoter (Stock no. 007004, Jackson Laboratory, Bar Harbor, ME, USA). Here, the CamKIIa promoter allows spatial control in the forebrain with temporal control of Egr-1 expression regulated by oral administration of doxycycline (Dox). Dox was withdrawn from their diet when they were 16-mo for the duration of 3 months to induce Egr-1 up-regulation. Littermates that were single positive for either Egr-1 or tetracycline-controlled transactivator were used as controls.
Cell culture
The human M17 neuroblastoma cell line (Sigma-Aldrich, Oakville, ON, Canada; 95011816, RRID: CVCL_0167) was maintained in a 1 : 1 mixture of Minimum Essential Medium and F12 medium and 10% fetal bovine serum (Life Technologies Inc., Burlington, ON, USA). Human Embryonic kidney 293 (HEK293) cells (SigmaAldrich; 85120602, RRID: CVCL_0045) and the monkey kidney tissue-derived cos-7 (CV-1 in Origin with SV40 genes) cell lines (Sigma-Aldrich; 87021302, RRID: CVCL_0224) were maintained in Dulbecco's Modified Eagle's Medium supplemented with 10% fetal bovine serum.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed using an EZMagna ChIP TM A Chromatin Immunoprecipitation Kit (Millipore, Toronto, ON, Canada) according to the manufacturer's instructions. Briefly, M17 cells were transfected with pCMV6-XL5-hEgr-1 for 48 h before cross-linking and chromatin isolation. The chromatin was then sheared to approximated 0.5-1 kb fragments, cross-linked and immunoprecipitated for 16 h at 4°C with an anti-Egr-1 antibody (Santa Cruz Biotechnology) or normal rabbit IgG as a negative control. Immunoprecipitated DNA fragments were amplified and quantitated by real-time PCR with PCR primers specific to the human drebrin promoter or a distant region on chromosome 5. The following primer sets with a slope between À3.1 and À3. Primary neuron culture Primary hippocampal cultures were prepared according to previously described methods (Jones et al. 2011) . Briefly, hippocampi were dissected from post-natal day 0 Sprague Dawley rats, dissociated by papain and sequentially titurated using Pasteur pipettes. Neurons were cultured on poly-L-lysine-coated coverslips or six-well plates in neuronal growth medium [Neurobasal-A medium (Life Technologies Inc.) supplemented with 2% B-27, 0.2% GlutaMAX-1, and penicillin-streptomycin (Life Technologies Inc.)]. 3-4 9 10 5 cells were plated per well of a 24-well plate for immunocytochemical analyses and 5-6 9 10 6 cells were plated per well of a six-well plate for western and qRT-PCR. After 3 h of plating, the coverslips were transferred into the 24-well plate containing a hippocampal astrocyte feeder layer maintained in neuronal growth medium or a six-well plate without feeder layer. Cytosine b-D-arabinofuranoside (SigmaAldrich), 3 lM, was added 4 days after plating.
Lentiviral vector production and administration
To create a lentivirus expressing Egr-1 (Ln-Egr-1), a human Egr-1 cDNA (OriGene, Rockville, MD, USA) with a C-terminus myc tag was subcloned into the bicistronic lentiviral expression vector pLVX-IRES-ZsGreen1 using Lenti-X TM HTX Packaging system (Clontech Laboratories Inc., Mountain View, CA, USA). A lentivirus expressing ZsGreen1 (Ln-vector) was created as a control. Titres for Ln-Egr-1 and Ln-vector ranged from 1 9 10 7 to 3910 8 IU/mL and 1 9 10 7 to 2 9 10 9 IU/mL, respectively. Primary neurons were infected (multiplicity of infection ranging from 5 to 25) on either the day of plating or after 7 days of culture by directly adding lentiviral preparations to the culture wells. The medium was replaced with conditioned neuronal growth medium after 12-24 h. 
Immunoblotting

Immunocytochemical staining and analyses
Hippocampal neurons on coverslips were fixed using 4% paraformaldehyde with 4% sucrose in 0.1 M phosphate-buffered saline for 10 min at 4°C. Washed cells were permeabilized (0.25% Triton X-100 for 5 min), washed, blocked for 45 min with 2% bovine serum albumin and goat serum in phosphate-buffered saline. The coverslips were incubated overnight at 4°C in primary antibodies and 1 h with corresponding Alexa 488-, 555-and 647-labeled secondary antibodies (Life Technologies Inc.). The coverslips were washed and mounted with ProLongâ Gold antifade reagent (Life Technologies Inc.). Z-stack confocal images (optical section thickness = 1 lm) were collected using a Zeiss LSM5 Pascal microscope and 63 9 oilimmersion objective. Ten to 15 GFP-positive neurons were chosen at random from two to five coverslips from three independent experiments for each treatment. Image J software was used for image processing and Reconstruct software for analyses. The experimenter was blind to the treatment conditions during quantification. The quantification was carried out as previously described with minor modifications (Takahashi et al. 2003) . Dendritic protrusions were identified using F-actin labeling. All clear protrusions > 0.5 lm and < 8 lm in length that emanated laterally from the dendrite were quantified while those projecting above and below were omitted. Dendritic protrusions were counted manually by scrolling through the Z-stacks at the same position. Dendritic protrusions next to each other were considered as separate spines if they were > 0.5 lm apart. The widths and lengths of protrusions were measured and used for morphological classification, Table 1 . The cluster of each protein was identified by a round staining region. For quantification of each post-synaptic protein cluster, round staining regions within the F-actin labeled dendritic protrusions were counted. PSD-95 cluster within dendritic protrusions were judged to be associated with a pre-synaptic terminal when the PSD-95-containing F-actin staining overlapped with vGluT1.
Golgi staining and analyses
Golgi staining of brain sections was performed using the FD Rapid GolgiStain Kit (FD NeuroTechnologies, Columbia, MD, USA) according to the manufacturer's instructions. Briefly, isolated brains were cut into 2 mm coronal sections using a brain matrix (Ted Pella, Inc., Redding, CA, USA). Brain sections were impregnated with a 1 : 1 mixture of FD Solution A:B for 2 weeks in the dark at room temperature and then immersed in FD Solution C for 48 h at 4°C in the dark. Tissue sections, 100 lm thick, were prepared using a Leica CM3050 S cryostat, (Richmond, IL, USA) mounted on 2% gelatincoated glass slides and allowed to dry at room temperature. Subsequently, sections were stained in 1 : 1 : 2 mixture of FD Solution D:E:distilled water, dehydrated, cleared in xylene, a coverslip added using Permount mounting solution (Fisher) and allowed to dry before quantitative analyses.
Z-stack confocal images (optical section thickness = 0.5 lm) of pyramidal neurons in the hippocampus CA1 region were taken using a Zeiss LSM5 Pascal microscope and 63 9 oil-immersion objective. Quantification was carried out using the rapid Golgi spine analysis method (Risher et al. 2014) . The experimenter was blind to the treatment conditions during quantification. Here, 10-15 neurons per animal were used for quantification. Neurons obscured by neighboring neurons or glia were excluded. For each neuron, straight branches longer than 10 lm were used for analysis, and dendritic segments between 30 and 220 lm from soma were quantified using Reconstruct software. Spine densities were calculated as number of spines per 10 microns. Also, the width and length of spines were measured. The same criterion was used as in Table 1 with an additional morphological classification, branched. If more than one spine head was observed on a single neck, the dendritic spine was classified as branched.
Statistics
All data were averaged across animals and cell lines within each experimental group. The data are presented as means AE SEM. Statistical comparisons were conducted by Student's t-test (paired, 2-tailed) and one-way ANOVA SPSS (IBM, North Castle, NY, USA) and GraphPad Prism 6.0 (GraphPad Software, Inc., La Jolla, CA, USA). Statistical significance was accepted at p < 0.05.
Results
Egr-1 binding sites on drebrin promoter Egr-1 regulates the expression of its target genes by binding to Egr-1-regulating elements (EREs) (GCG(G/T)GGGCG) present on their promoter (Milbrandt 1987) . To identify EREs in the drebrin promoter, we performed in silico analysis of the 5 kb sequence upstream of the transcriptional start site of human drebrin gene using Whole Genome RVista. We identified three putative EREs located on À2430 bp (GgGTGGGaG), À245 bp (GgGGGGGCG), and -85 bp (GCGGcGGCG) (Fig. 1a) . To substantiate these regions as containing putative Egr-1 binding sites, we investigated their proximity to Egr-1 binding sites identified from ChIP-seq data available on UCSC Genome Browser. We found overlap in sampling that explored nonneuronal K562 leukemia cells (À2740 to À2675 bp), GM12878 B-lymphocytes, and H1-hESC human embryonic stem cells (À347 to À72 bp) (Fig. 1b) . Therefore, these ERE sites are conserved in the drebrin promoter in non-neuronal cells.
To establish the interaction between Egr-1 transcription factor and drebrin promoter in a neuronal cell, we used a ChIP assay and the neuronal cell line -M-17 neuroblastoma. Four primer sets were designed to amplify DNA approximately À2800 bp, À1500 bp, À500 bp, and +50 bp from the transcriptional start site in close proximity to the putative EREs (Fig. 1c ). An additional primer set downstream of the drebrin gene was used as an off-target control. Two regions showed > 4-fold enrichment (p < 0.0001) when compared with the off-target control (Fig. 1d) . The 4.2-fold enrichment observed at À2800 bp likely corresponds to the ERE at À2430 bp, while the 4.9-fold enrichment at -500 bp corresponds to the ERE at À245 bp. The other two primer sets also had significant enrichment of Egr-1 where 1.8-and 2.3-fold increase was observed for positions À1500 bp and +50 bp, respectively (p < 0.0001). These results suggest that the drebrin promoter contains multiple sites for potential Egr-1 binding with at least two EREs in the proximity of À2430 bp and À245 bp.
Egr-1 over-expression in primary hippocampal neurons
We examined the changes in drebrin expression in response to Egr-1 up-regulation. To test the effect of Egr-1 upregulation on drebrin expression, we over-expressed Egr-1 in vitro using lentiviral transduction. Primary hippocampal neurons isolated from P0 rats were infected with either Ln- Egr-1 or Ln-Vector on the day of isolation, and cell lysates for RNA and protein analyses were prepared 9 days later. Both Ln-Egr-1 and Ln-Vector express ZsGreen1 as a transduction reporter. Based on the reporter ZsGreen1 fluorescence, we found that both virus types had similar transduction efficiencies in primary neurons that we estimated to be between 40 and 50% (Fig. 2a) . The transduced neurons showed greatest ZsGreen1 expression in the cell nucleus and soma (Fig. 2b) . Significant over-expression of Egr-1 mRNA and protein was evident from lentiviral transduction ( Fig. 2c and d) . At the mRNA level, Egr-1 was increased by 5.7-fold (p < 0.0001) when compared with the vector control. At the protein level, a 19.6-fold increase (p < 0.0001) in Egr-1 protein was confirmed by probing for either the myc tag or Egr-1 protein where the inserted human Egr-1 protein migrated at approximately 87 kDa. These results indicate successful transduction of primary neurons with Ln-Egr-1 and up-regulation of Egr-1 expression.
The up-regulation of Egr-1 led to down-regulation of drebrin mRNA and protein levels ( Fig. 2e and f) . qPCR analysis revealed that drebrin mRNA was reduced significantly by 77% (p < 0.0001), while immunoblotting showed a significant 48% reduction (p < 0.0001) in drebrin protein.
These data suggest that Egr-1 up-regulation negatively regulates drebrin expression in primary neuronal cultures in vitro.
Egr-1 up-regulation in an inducible model of Egr-1 over-expression in vivo To corroborate the in vitro data, we generated an inducible mouse model of Egr-1 (Egr-1 Tg) using the tet-off system (Fig. 3a) . Here, expression of Egr-1 is controlled spatiotemporally. For spatial control, the use of Ca 2+ /calmodulindependent protein kinase IIa (CamKIIa) promoter directs Egr-1 expression to the forebrain that includes hippocampus and prefrontal cortex, but not the cerebellum. Increased Egr-1 expression is achieved temporally by removal of doxycycline (dox) from the diet.
In accordance with the observation that Egr-1 up-regulation is observed in AD which manifests later in life (Gomez Ravetti et al. 2010), we induced Egr-1 expression in 16-mo aged Egr-1 Tg mice. Here, the Egr-1 Tg mice were allowed to develop normally until they reached an age comparable with an elderly human counterpart. Three months after induction, Egr-1 and drebrin levels were measured in samples from the hippocampus, prefrontal cortex, and cerebellum using qRT-PCR and immunoblotting, (Fig. 3b-g ). Up-regulation of Egr-1 mRNA and protein was confirmed in the hippocampus and prefrontal cortex of the Egr-1 Tg mouse (Fig. 3b, d-f ). Egr-1 mRNA was increased in the hippocampus and prefrontal cortex (42-and 32-fold, respectively (p < 0.0005). Further, Egr-1 protein was increased in the hippocampus and prefrontal cortex when expression of the inserted human Egr-1 or its myc tag was assessed.
We found Egr-1 induction in aged Egr-1 Tg mouse led to significant reductions in drebrin mRNA in the hippocampus and protein level in the hippocampus and prefrontal cortex but not cerebellum (Fig. 3c-g ). Drebrin mRNA was significantly reduced by 52% in the hippocampus (p < 0.005), (Fig. 3c) although the reduction in drebrin mRNA expression did not reach statistical significance in the prefrontal cortex (p = 0.067). A significant decrease in drebrin protein level was evident both in the hippocampus and prefrontal cortex, by 16% and 25%, respectively (p < 0.0005) (Fig. 3g) . Overall, these results suggest that Egr-1 up-regulation leads to loss of drebrin in vivo.
Drebrin expression in Egr-1À/À mouse
Our data consistently show that Egr-1 up-regulation leads to down-regulation of drebrin in vitro and in vivo. To further substantiate the negative regulation of drebrin by Egr-1, we examined drebrin protein levels in response to Egr-1 loss-offunction using Egr-1À/À mice. Immunoblotting of whole brain homogenates from Egr-1+/+, Egr-1+/À, and Egr-1À/À revealed a significant and dose-dependent increase in drebrin protein level from Egr-1+/+ to Egr-1+/À (1.37-fold, p < 0.0001) to Egr-1À/À mouse (1.87-fold compared to Egr-1+/+, p < 0.0001; and 1.36-fold compared to Egr-1+/À, p < 0.0005) (Fig. 4a) .
To examine brain-specific regional changes in drebrin expression, drebrin expression was measured in the hippocampus, prefrontal cortex, and cerebellum. qRT-PCR and immunoblotting revealed significant increases in drebrin mRNA and protein levels in Egr-1À/À compared with Egr-1+/+ mice in the hippocampus and prefrontal cortex, but not cerebellum (Fig. 4b) . At the mRNA level, Egr-1À/À mice had significantly 2.2-(p < 0.0005) and 3.7-fold (p < 0.0001) increased levels of drebrin compared with Egr-1 + /+ mice in the hippocampus and prefrontal cortex, respectively. Similarly, the protein level was increased significantly (p < 0.0001) by 1.7-and 1.6-fold in the hippocampus and prefrontal cortex, respectively, in Egr-1À/À mice (Fig. 4c) . Therefore, reductions in Egr-1 expression in vivo were associated with increases in drebrin expression. These data support our finding that Egr-1 is a negative regulator of drebrin expression. qRT-PCR analysis for drebrin mRNA and (c) immunoblotting for drebrin protein in the hippocampus, prefrontal cortex, and cerebellum show increased drebrin level in the hippocampus and prefrontal cortex. *p < 0.0001; **p < 0.0005. Error bars indicate mean AE SEM.
Changes in dendritic spine density in response to Egr-1 up-regulation Reduced drebrin is associated with loss of dendritic spines (Harigaya et al. 1996; Shim and Lubec 2002; Kojima and Shirao 2007) . To test whether Egr-1-mediated reductions in drebrin are linked with altered dendritic spine morphology, we quantified dendritic protrusion density and characterized the protrusion morphology when Egr-1 was up-regulated (Fig. 5) . Rat primary hippocampal neurons were transduced with Ln-Egr-1 or Ln-vector on the day of isolation. To visualize the morphology of dendritic protrusions, F-actin-and drebrinspecific staining was assessed after 16 days in culture (Fig. 5a ). We found a significantly reduced density of dendritic protrusions in Egr-1 up-regulated neurons compared with the Lnvector control. Egr-1-transduced neurons had significantly reduced protrusion density (2.3 AE 0.2 protrusions/10 lm) when compared with the vector-transduced neurons (4.8 AE 0.2 protrusions/10 lm) (p < 0.0001) (Fig. 5b) . Furthermore, dendritic protrusions of Egr-1-transduced neurons contained proportionately fewer drebrin clusters (1.85 out of 2.72 protrusions/10 lm; 68.0%) (p < 0.0001) compared with Lnvector neurons (4.62 out of 4.8 protrusions/10 lm; 96.3%) (Fig. 5b) . These results suggest a drop in protrusion density because of Egr-1-mediated reductions in drebrin expression, which may have decreased the number of drebrin-positive dendritic protrusions.
To measure the changes in the morphological distribution of dendritic protrusions in response to Egr-1 up-regulation, the lengths and widths of individual protrusions were measured. The measurements were used to categorize and to compare structural differences between the dendritic protrusions of Ln-Egr-1 versus Ln-vector-transduced neurons (Fig. 5c) . Each protrusion was classified as filopodia, thin, stubby, or mushroom shaped (Table 1) . According to the morphology, these protrusions were categorized into filopodia, structurally mature spines, and immature spines. Previous imaging experiments have indicated that there is a correlation between spine head size and synaptic strength where large heads conferred more stability and activity by expressing a greater number of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) (Kasai et al. 2003; Hayashi et al. 2005) . Based on these observations, we categorized mushroom-shaped protrusions/ spines as mature spines while thin and stubby spines were categorized as immature spines (Bourne and Harris 2007) . As a result, we found that Egr-1 up-regulation did not significantly alter the morphological distribution of dendritic protrusions. The majority of the protrusions were classified as mature mushroom spines (48.7% for Ln-Egr-1 vs. 60.3% for Ln-Vector, p = 0.057) followed by filopodia (22.7% for Ln-Egr-1 vs. 23.6% for Ln-Vector, p = 0.917) and immature thin and stubby spines (27.5% for Ln-Egr-1 vs. 17.1% for Ln-Vector, p = 0.330). Therefore, we demonstrate that Egr-1 up-regulation leads to a reduction in dendritic protrusion density, without significantly altering spine morphology.
To corroborate these in vitro findings, we quantified dendritic spine density in the CA1 region of the hippocampus in Egr-1 Tg mice. The CA1 region of the hippocampus was chosen because of its susceptibility to synaptic pathology as well as high Egr-1 expression (Beckmann and Wilce 1997) , on the basis suggesting that Egr-1-mediated losses in spine density would be greatest in this region. Golgi staining of the hippocampal neurons (Risher et al. 2014 ) revealed a significant decrease in dendritic spine density in Egr-1 Tg mice (3.7 AE 0.1 spines/10 lm) compared with (6.2 AE 0.2 spines/ 10 lm) for the control (p < 0.0001) (Fig. 6a and b) . Therefore, Egr-1 up-regulation in vivo leads to reductions in hippocampal drebrin and dendritic spine.
We also quantified the dendritic spines according to their morphology as was done for hippocampal neurons (Fig. 6c) . In addition to filopodia, thin, stubby, and mushroom spines, we also observed branched spines. Spines were defined as branched spines when two spine heads were observed on a single spine neck. The branched spines are thought to be transitory spines that lead to increased synaptic plasticity in long-term potentiation (Harris et al. 2003; Mahmmoud et al. 2015) , and thus, were included in the immature spine category. Regarding the morphological distribution of dendritic spines, we found that Egr-1 up-regulation did not alter the overall mature-to-immature spine distribution (Fig. 6c) . The majority of the neurons in Egr-1 Tg and control mice had mature mushroom spines (75.8% for Egr-1 Tg vs. 68.6% for the control, p = 0.153) followed by immature thin, stubby and branched spines (23.5% for Egr-1 Tg vs. 30.0% for the control, p = 0.268), and filopodia (0.7% for Egr-1 Tg vs. 1.8% for the control, p = 0.308). However, a significant difference was observed for immature branched spines (0% for Egr-1 Tg vs. 1.8% for the control, p < 0.05) (Fig. 6c) . Therefore, Egr-1 up-regulation leads to reduction in dendritic spine density without affecting spine morphology.
Dendritic spine density in Egr-1À/À mouse To test whether increased drebrin translated into increased dendritic spine density, spine density was quantified in CA1 hippocampal neurons of 12-month old Egr-1À/À and Egr-1+/+ control mice. Golgi staining revealed a significant increase in dendritic spine density in CA1 region of hippocampus in Egr-1À/À (7.8 AE 0.2 spines/10 lm) compared with (4.9 AE 0.2 spines/10 lm) Egr-1+/+ mouse (p < 0.0001) (Fig. 7a and b) . These data further support the previous findings that drebrin expression and dendritic spine density are positively correlated. As previously mentioned, spine morphology was comparable (Fig. 7c) . Therefore, changes in Egr-1-mediated drebrin level did not change the overall distribution of spine morphology. Egr-1 up-regulation-mediated changes in other synaptic proteins To establish whether Egr-1-mediated reductions in drebrin lead to changes in other synaptic proteins, we quantified PSD-95 clusters within dendritic protrusions, a major scaffolding protein recruited by drebrin (Takahashi et al. 2003) . Hippocampal neurons were transduced with Ln-Egr-1 or Ln-vector and F-actin, drebrin, and PSD-95 expressions were identified (Fig. 8) . In response to Egr-1 up-regulation, we found a significant reduction in the density of dendritic protrusions that contained both PSD-95 and drebrin clusters ( Fig. 8a and b) compared with the control (65.5% vs. 94.8%, respectively). For both Ln-Egr-1-and Ln-vector-transduced neurons, majority of PSD-95 clusters were present along with drebrin clusters; only 0.07 out of 2.61 protrusions/10 lm and 0.06 out of 4.81 protrusions/10 lm contained PSD-95 clusters without drebrin clusters (p < 0.0001) (Fig. 8b) . These findings together with our earlier observation, that fewer dendritic protrusions contained drebrin clusters in response to Egr-1 up-regulation compared with the control (refer to Fig. 5c and d) , support the idea that drebrin is required for the localization of PSD-95 to the spines. Therefore, Egr-1 mediated reductions in drebrin lead to fewer protrusions with reduced PSD-95. Based on these data, we hypothesized that Egr-1 upregulation may also lead to overall loss of synaptic contacts. To examine this, Ln-Egr-1-and Ln-vector-transduced neurons were prepared and immunolabeled for F-actin, PSD-95, and the pre-synaptic marker vesicular glutamate transporter 1 (vGluT1) (Fig. 8c) . Synaptic association of vGluT1 and PSD-95 suggest the presence of putative functional glutamate synaptic contacts (van der Stelt et al. 2011). For our study, we considered vGluT1 and PSD-95 to be associated when both protein clusters were localized to same dendritic protrusion. We found presence of both vGluT1 and PSD-95 in 3.65 protrusions out of 4.7 protrusions/10 lm in vector control samples (Fig. 8d) . In contrast, Egr-1 up-regulation led to greater reductions in the proportion of dendritic protrusions with both vGluT1 and PSD-95 (1.27 out of 2.82 protrusions/10 lm, p < 0.0001). Thus, only 45.0% of the dendritic protrusions in Egr-1-up-regulated neurons had putative functional synaptic contacts compared with 77.7% for the control. These data suggest that Egr-1-mediated reduction in drebrin expression lead to decreased formation of mature dendritic spines and putative synaptic contacts.
To confirm these data, we measured the expression of a panel of synaptic proteins in Ln-Egr-1-and Ln-vectortransduced hippocampal neurons using immunoblotting (Fig. 9a) . We found that Egr-1-mediated reductions in drebrin did not alter the protein levels of the ABPs cofilin (p = 0.44) and profilin (p = 0.61), (Fig. 9b) . However, expression of the post-synaptic proteins GluA1 and PSD-95 was significantly reduced by 46.2% (p < 0.005) and 29.5% (p < 0.05), respectively. In contrast, the pre-synaptic protein vGluT1 was significantly increased by 1.57-fold (p < 0.05). These data suggest that Egr-1-mediated downregulation of drebrin corresponded to reduced expression of a subset of other synaptic proteins.
Discussion
In this study, we demonstrate for the first time that Egr-1 is a negative regulator of drebrin expression and expand the current knowledge of drebrin and dendritic spine regulation. We have shown that: 1. Egr-1 interacts with the drebrin promoter; 2. Egr-1 negatively regulates drebrin expression in vitro and in vivo; 3. Sustained up-regulation of Egr-1 leads to loss of dendritic spines in vitro and in vivo.
Role of Egr-1 in regulating drebrin expression The drebrin promoter contains 60% GC-content, which presents Egr-1 with multiple consensus and non-consensus EREs because Egr-1 is able to associate with 9-bp GC-rich sequences that closely resemble the consensus sequence (Kubosaki et al. 2009 ). Our ChIP data shows that Egr-1 interacts with the drebrin promoter, and that changes in Egr-1 expression result in synchronous changes in drebrin mRNA and protein but not in other ABPs. These data support our hypothesis that Egr-1 functions as a transcriptional regulator of drebrin expression. This is also in line with high-density microarray data that showed a 23% loss of drebrin in Egr-1-up-regulated PC12 cells (James et al. 2005) . For confirmation of direct Egr-1 binding to drebrin promoter, it would be informative to also conduct mutagenesis for each EREs as well as electrophoretic mobility shift assays.
With respect to regulation of drebrin expression, previous studies have shown transcription factors NXF and Sim2 of the basic helix-loop-helix-Per-Arnt-Sim protein family to bind to drebrin promoter (Ooe et al. 2004) . NXF was shown to activate drebrin promoter using reporter gene assay, DNA array technology, and ChIP assay, while Sim2 was shown to repress drebrin transcription according to reporter gene assay (Vialard et al. 2000) . Functionally, these studies led to implicate Sim2 as a regulatory factor responsible for drebrin loss in Down's syndrome as a result of Sim2 0 s trisomic state (Ema et al. 1999) and possibly in AD. However, in AD, no significant change in Sim2 was found between AD and control patients (Shim et al. 2003) , and Sim2 and drebrin showed weak positive correlation when analyzed by linear regression (Julien et al. 2008) . These data suggest that different TFs are responsible for drebrin loss in different cognitive disorders.
Egr-1, under physiological conditions including growth and development, is thought to regulate synaptic plasticity, neurite outgrowth, and wound repair (Khachigian et al. 1996; Harada et al. 2001; Jones et al. 2001) . However, upregulation of Egr-1, which is observed in AD, has been shown to facilitate pathology (MacGibbon et al. 1997; Gomez Ravetti et al. 2010; Bakalash et al. 2011; Lu et al. 2011; Gatta et al. 2014; Killick et al. 2014) . Indeed, Egr-1 was shown to up-regulate presenilin-2 gene expression and facilitate the c-secretase cleavage of amyloid precursor protein (Renbaum et al. 2003) . Recently, we have also found Egr-1 up-regulation induces b-secretase 1 (BACE-1) expression and promotes Ab synthesis (Qin et al. 2016) . Furthermore, we showed previously that Egr-1 expression correlated with hyperphosphorylated tau (Lu et al. 2011) . In addition, we show here that deliberate over-expression of Egr-1 disrupts drebrin expression and dendritic spine density, which also occurs in AD. These results suggest that up-regulation of Egr-1 may lead to neuronal dysfunction and exacerbate AD-related pathologies.
The mechanisms leading to increased Egr-1 that would contribute to pathology are not well known. Normally in the CNS, Egr-1 expression is induced by activation of NMDARs (Beckmann and Wilce 1997) . It has been found that NMDARs are over-activated in AD (Kelly and Ferreira 2006; Texido et al. 2011) . Therefore, we speculate that activation of NMDAR may recruit Egr-1 to drebrin promoter and lead to its down-regulation. Another possibility, which is not mutually exclusive, is the involvement of P21-activated kinase (PAK)/LIM-kinase (LIM-K) pathway. LIM-K pathway was proposed to indirectly regulate drebrin by regulating cofilin that competes with drebrin for actin-binding sites . In support, PAK over-expression in primary hippocampal neurons prevented drebrin loss despite the exposure to Ab (Zhao et al. 2006) . In relation to Egr-1, it was shown in cancer cells that treatment with PAK5 siRNA led to an increase in Egr-1 expression (Wang et al. 2013) , and PAK/LIM-K activities are reduced in AD. Although the mechanisms that might lead to increased Egr-1 in AD are not well known, these data suggest an inverse relationship between neuronal-specific PAK5 and Egr-1 where reductions in PAK5 would contribute to increases in Egr-1. Together, Egr-1 up-regulation is likely to be caused by multiple factors and further investigations are needed to identify the factors and the degree to which they drive Egr-1 up-regulation.
Following Egr-1 activation, the underlying mechanisms of epigenetics and downstream target gene regulation remain largely undetermined. For Egr-1-mediated repression, it has been postulated that Egr-1 represses a transcription by competing with transcription factor Sp-1, which activate its target genes under normal circumstances (Tatarowicz et al. 1997; Bedadala et al. 2007) . Sp-1 also contains Cys 2 /His 2 -type zinc fingers as Egr-1, and thus, binds to GC-rich sequences that often overlap with EREs. Therefore, it is possible that Egr-1 may compete with activating transcription factors that bind to GC-rich domain on the drebrin promoter and lead to its down-regulation. Egr-1 binding to drebrin promoter could lead to epigenetic changes involving histone methylation and/or deacetylation, although one particular study found that histone deacetylation was not associated with Egr-1-mediated repression (Bedadala et al. 2007 ).
Egr-1-mediated changes in dendritic spines
The correlation between loss of drebrin and dendritic spines has been studied in depth with respect to cognitive disorders using various in vitro and in vivo models (Harigaya et al. 1996; Shim and Lubec 2002; Takahashi et al. 2006; Biou et al. 2008; Jung et al. 2015; Ma et al. 2015) . Similarly, our in vitro and in vivo data collectively show that downregulation of drebrin mediated by Egr-1 up-regulation result in reduction of dendritic spine density without changes in the mature-to-immature spine distributions. These data suggest that Egr-1-mediated down-regulation of drebrin affects both mature and immature spines similarly unlike those observed in direct knockdown of drebrin where it led to formation of thin immature spines in hippocampal neurons (Takahashi et al. 2006) . Therefore, changes in the upstream regulation of drebrin appear to have a more moderate effect on drebrin and spine morphology, whereas Egr-1 regulates drebrin which remains equally present in both immature and mature spines.
In addition to the lower dendritic spine density, Egr-1 upregulation in cultured hippocampal neurons prevented the formation of mature spines and synaptic contacts as was implicated by reduced association of PSD-95 and vGluT1. The association of PSD-95 and vGluT1 implies the presence of synaptic contact. Drebrin is required for PSD-95 and actin clustering at dendritic spines (Takahashi et al. 2003) . Therefore, down-regulation of drebrin by Egr-1 TF may prevent the accumulation of PSD-95 in dendritic spines as shown by our data where Egr-1 up-regulation led to reduced co-localization of drebrin and PSD-95. Our immunofluorescence data was further supplemented by the immunoblotting data where Egr-1 up-regulation led to a decrease in PSD-95 expression. This is in support of our recent finding that showed Egr-1 is a transcriptional repressor of PSD-95 (Qin et al. 2015) . These data indicate that Egr-1 upregulation can directly down-regulate PSD-95 expression and indirectly prevent PSD-95 accumulation at dendritic spines by down-regulating drebrin. Loss of PSD-95 accumulation, in turn, may disrupt AMPAR and NMDAR recruitment to the post-synaptic membrane (Beique et al. 2006; Takahashi et al. 2006; Ma et al. 2015) . It is possible that both down-regulation of drebrin and PSD-95 may be contributing to a decreased dendritic spine density, although PSD-95 knockout had no influence on spine morphology (Migaud et al. 1998) . In mature neurons of 14DIV, colocalization of PSD-95 and vGluT1 correlated with the amplitude of the post-synaptic response in AMPA-type glutamate receptor currents (Kay et al. 2011) . On the basis Dendritic protrusions were identified using F-actin labeling (red arrowheads). Drebrin clusters (white arrowheads) and PSD-95 cluster (yellow arrowheads) within dendritic protrusions were quantified. They were considered co-localized when both drebrin and PSD-95 clusters were present within the same dendritic protrusion (arrows). (b) Quantification of co-localization of drebrin and PSD-95 or PSD-95 only shows significant decrease in co-localization when Egr-1 is upregulated. (c) Immunolabeling of 16 DIV hippocampal neurons transduced with Ln-vector or Ln-Egr-1 for F-actin, PSD-95, and vGluT1. Dendritic protrusions were identified using F-actin labeling (red arrowheads). vGluT1 clusters (white arrowheads) and PSD-95 cluster (yellow arrowheads) within dendritic protrusions were quantified. vGluT1 and PSD-95 were considered associated when both drebrin and PSD-95 clusters were present within the same dendritic protrusion (arrows). (d) Quantification of co-localization of PSD-95 and vGluT1 showed greater decrease in co-localization of PSD-95 and vGluT1 in Egr-1 up-regulated neurons when compared with Ln-Vector control. *p < 0.0005; **p < 0.0001; ***p < 0.001. Scale bars: 10 lm. Errors bars indicate mean AE SEM.
of this knowledge, we predict that decrease in synaptic contacts would correlate with the decrease in synaptic activity.
Egr-1 mouse models and implications Our Egr-1 mouse models showed brain region-specific upregulation and complete deficiency of Egr-1 influenced drebrin expression and dendritic spine density. Based on our data, aberrant changes of Egr-1 in CNS likely yield dysfunctional and possibly detrimental changes in synaptic properties.
In this study, Egr-1 Tg mice displayed loss of drebrin and dendritic spine density when Egr-1 was up-regulated for a long term in the brain, lasting 90 days. Our finding is in contrast to similar studies where 702-703 inducible mouse models of Egr-1 were used to reveal Egr-1 0 s physiological role in memory consolidation (Beckmann and Wilce 1997; Baumgartel et al. 2008; Penke et al. 2014) . In these studies, it was found that transient induction of Egr-1 (6-8 days prior to experiments) contribute to strengthening of newly formed memories (Khachigian et al. 1996; Beckmann and Wilce 1997; Harada et al. 2001; Jones et al. 2001) . However, as shown previously and herein, chronic up-regulation of Egr-1 found in cognitive disorders such as AD was found to be associated with pathology. It remains to be seen whether reduced drebrin translates into cognitive impairment in our Egr-1 Tg mouse model.
On the other hand, Egr-1 loss-of-function in Egr-1À/À led to increased levels of drebrin and spine density. An increase in spine density is positively correlated with enhanced longterm potentiation and memory consolidation (Leuner et al. 2003; Matsuzaki et al. 2004; Jedlicka et al. 2008; BeltranCampos et al. 2011; Lamprecht 2011; Conrad et al. 2012; Eilam-Stock et al. 2012) . Furthermore, we have recently found significantly reduced levels of Ab and BACE-1 in Egr-1À/À mice, which are believed to cause amyloid pathology in AD (Qin et al. 2016) . However, Egr-1À/À mice lack late protein synthesis-dependent LTP in the dentate gyrus leading to impaired long-term spatial memory (Jones et al. 2001) . Also, the CA1 place cells of Egr-1À/À mice are impaired in terms of maintaining long-term place fields, which is an essential component of the spatial memory system (Renaudineau et al. 2009 ). These discordant results point to the idea that Egr-1 levels must be finely controlled; while upregulation of Egr-1 leads to drebrin and dendritic spine loss, physiological levels of Egr-1 are necessary for memory formation.
Taken together, these results show novel roles of Egr-1 in regulating drebrin and dendritic spine function. These findings add to the growing list for the potential pathological consequence of Egr-1 up-regulation. Furthermore, the findings highlight the importance modulating Egr-1 within physiological range in order to facilitate homeostatic synaptic symmetry.
